Cardio Diagnostics Holdings's three largest insider shareholders as of September 09, 2026 are Robert Philibert (Chief Medical Officer, 1.68Mn shares), Meeshanthini Dogan (Chief Executive Officer, 1.66Mn shares), Robert Philibert (Chief Medical Officer, 1.63Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Robert Philibert | Chief Medical Officer | 0 | 1,683,867 | 1,683,867 | 45.4% | 10 Sep, 2024 |
| 2 | Meeshanthini Dogan | Chief Executive Officer | 1,655,429 | 0 | 1,655,429 | 44.6% | 08 Oct, 2024 |
| 3 | Timur Dogan | Chief Technology Officer | 197,310 | 0 | 197,310 | 5.3% | 09 Oct, 2024 |
| 4 | Stanley K. Lau | Director | 100,325 | 0 | 100,325 | 2.7% | 08 Apr, 2024 |
| 5 | Oded Levy | Director | 71,596 | 0 | 71,596 | 1.9% | 08 Apr, 2024 |
| 6 | Paul Frederick Burton | Director | 293 | 0 | 293 | 0.0% | 08 Apr, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 30 Jun, 2026 | James Intrater | Director | Acquired A | 2,854 | $2.19 | $6.25K | 13,318 | Direct |
| 30 Jun, 2026 | Wendy J Betts | Director | Acquired A | 2,854 | $2.19 | $6.25K | 12,367 | Direct |
| 30 Jun, 2026 | Peter K Fung | Director | Acquired A | 2,854 | $2.19 | $6.25K | 12,367 | Direct |
| 30 Jun, 2026 | Paul Frederick Burton | Director | Acquired A | 2,854 | $2.19 | $6.25K | 13,318 | Direct |
| 31 Mar, 2026 | Wendy J Betts | Director | Acquired A | 3,205 | $1.95 | $6.25K | 9,513 | Direct |
| 31 Mar, 2026 | Paul Frederick Burton | Director | Acquired A | 3,205 | $1.95 | $6.25K | 10,464 | Direct |
| 31 Mar, 2026 | Peter K Fung | Director | Acquired A | 3,205 | $1.95 | $6.25K | 9,513 | Direct |
| 31 Mar, 2026 | Peter K Fung | Director | Acquired A | 3,205 | $1.95 | $6.25K | 9,513 | Direct |
| 31 Mar, 2026 | Peter K Fung | Director | Acquired A | 3,205 | $1.95 | $6.25K | 9,513 | Direct |
| 31 Mar, 2026 | Peter K Fung | Director | Acquired A | 3,205 | $1.95 | $6.25K | 9,513 | Direct |
| 31 Dec, 2025 | Peter K Fung | Director | Acquired A | 2,306 | $2.71 | $6.25K | 6,308 | Direct |
| 31 Dec, 2025 | Wendy J Betts | Director | Acquired A | 2,306 | $2.71 | $6.25K | 6,308 | Direct |
| 31 Dec, 2025 | Peter K Fung | Director | Acquired A | 2,306 | $2.71 | $6.25K | 6,308 | Direct |
| 31 Dec, 2025 | Paul Frederick Burton | Director | Acquired A | 2,306 | $2.71 | $6.25K | 7,259 | Direct |
| 31 Dec, 2025 | Peter K Fung | Director | Acquired A | 2,306 | $2.71 | $6.25K | 6,308 | Direct |
| 31 Dec, 2025 | Peter K Fung | Director | Acquired A | 2,306 | $2.71 | $6.25K | 6,308 | Direct |
| 30 Sep, 2025 | Peter K Fung | Director | Acquired A | 1,559 | $4.01 | $6.25K | 4,002 | Direct |
| 30 Sep, 2025 | Peter K Fung | Director | Acquired A | 1,559 | $4.01 | $6.25K | 4,002 | Direct |
| 30 Sep, 2025 | Peter K Fung | Director | Acquired A | 1,559 | $4.01 | $6.25K | 4,002 | Direct |
| 30 Sep, 2025 | Peter K Fung | Director | Acquired A | 1,559 | $4.01 | $6.25K | 4,002 | Direct |